Generic Drugs Market Research Reports

Our range of reports on generics, biosimilars and biobetters will help you to gain an accurate view of the current and future generics landscape. They will help you gain insight as to how to discover techniques to counter patent expiry, manage drug life cycles, identify opportunities for market entry, and benchmark performance.


Filter
Title Search
1 - 25 of 130 Products Sort by Display
Generic Drugs Markets in China
Published by
Asia Market Information & Development
Product code
358264
Published
May 10, 2018
Content info
220 Pages
Price
USD 4000
Sample available
Generic Injectables Market (Large Molecule Injectables (Biosimilars), Small Molecule Injectables) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
Published by
Transparency Market Research
Product code
635229
Published
April 19, 2018
Content info
203 Pages
Price
USD 5795
Sample available
Biosimilars Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2016 - 2025
Published by
Variant Market Research LLP
Product code
629522
Published
April 16, 2018
Content info
102 Pages
Price
USD 3195
Sample available
Biosimilars Market by Product (Recombinant Non-Glycosylated Proteins (Insulin, rHGH, Interferon), Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-house, Contract), Disease (Oncology, Autoimmune) - Global Forecast to 2023
Published by
MarketsandMarkets
Product code
290171
Published
April 6, 2018
Content info
183 Pages
Price
USD 5650
Sample available
Biosimilars: US Payer Perspectives (2018)
Published by
FirstWord
Product code
328749
Published
April 1, 2018
Content info
 
Price
USD 2495
Sample available
Biosimilar Index: Tracking the Biosimilar Development Landscape
Published by
FirstWord
Product code
298599
Published
annual subscription
Content info
Database + 135 Slides
Price
USD 19000
Sample available
Biosimilars: Global Markets
Published by
BCC Research
Product code
242224
Published
March 28, 2018
Content info
340 Pages
Price
USD 3950
Sample available
*
Published by
MarketLine
Product code
483010
Published
February 28, 2018
Content info
110 Pages
Price
USD 995
Sample available
Generics Top 5 Emerging Markets Industry Guide 2017-2021
Published by
MarketLine
Product code
353043
Published
February 28, 2018
Content info
124 Pages
Price
USD 995
Sample available
*
Published by
MarketLine
Product code
353040
Published
February 28, 2018
Content info
163 Pages
Price
USD 1495
Sample available
Generics Global Industry Almanac 2017-2021
Published by
MarketLine
Product code
353039
Published
February 28, 2018
Content info
449 Pages
Price
USD 2995
Sample available
Generics Global Industry Guide 2017-2021
Published by
MarketLine
Product code
251357
Published
February 28, 2018
Content info
247 Pages
Price
USD 1495
Sample available
Global Biosimilar Monoclonal Antibodies Forecast 2018-2028: Biosimilar Versions of Infliximab, Rituximab, Trastuzumab, Adalimumab, Bevacizumab and Abciximab
Published by
Visiongain Ltd
Product code
275993
Published
February 27, 2018
Content info
204 Pages
Price
USD 3914
Sample available
US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023
Published by
IMARC Services Pvt. Ltd.
Product code
359386
Published
February 4, 2018
Content info
84 Pages
Price
USD 1499
Sample available
Biosimilars: EU Payer Perspectives
Published by
FirstWord
Product code
326352
Published
February 1, 2018
Content info
 
Price
USD 2495
Sample available
Biosimilar Insulin Market Access
Published by
Datamonitor Healthcare
Product code
498961
Published
January 26, 2018
Content info
19 Pages
Price
USD 5000
Sample available
Biosimilars Market Access in the EU
Published by
Datamonitor Healthcare
Product code
604015
Published
January 19, 2018
Content info
137 Pages
Price
USD 7500
Sample available
APAC Biosimilar Market, Forecast 2025
Published by
Frost & Sullivan
Product code
602441
Published
January 10, 2018
Content info
160 Pages
Price
USD 4950
Sample available
*
Published by
Kalorama Information
Product code
96359
Published
November 14, 2017
Content info
214 Pages
Price
USD 4500
Sample available
U.S. Specialty Injectable Generics Market Analysis By Therapeutic Use (Oncology, Cardiovascular, Central Nervous System, Infectious Diseases, Autoimmune Disorders), And Segment Forecasts, 2014 - 2025
Published by
Grand View Research, Inc.
Product code
600800
Published
November 2, 2017
Content info
76 Pages
Price
USD 5950
Sample available
Competitor Analysis: Anti-VEGF and Anti-VEGF-R Biosimilars and Biosuperiors of Avastin, Cyramza, Eylea and Lucentis - 2017 Update
Published by
La Merie Publishing
Product code
358307
Published
November 2, 2017
Content info
58 Pages
Price
USD 525
Sample available
*
Published by
Stratistics Market Research Consulting
Product code
599839
Published
November 1, 2017
Content info
167 Pages
Price
USD 4150
Sample available
*
Published by
FirstWord
Product code
581398
Published
November 1, 2017
Content info
 
Price
USD 2245
Sample available
Clinical Trial Strategies in Biosimilar Drug Development
Published by
Datamonitor Healthcare
Product code
573565
Published
October 13, 2017
Content info
149 Pages
Price
USD 10000
Sample available
*
Published by
MP Advisors
Product code
565345
Published
October 13, 2017
Content info
104 Pages
Price
USD 4000
Sample available